Enlivex rStock

RENLV

Enlivex Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing immunomodulatory therapies. Utilizing its proprietary macrophage reprogramming technology platform, the company researches innovative treatments for sepsis, solid tumors, and autoimmune diseases.